Llwytho...
Acquired Hemophilia A Successfully Treated with Rituximab
Acquired hemophilia A (AHA) is a rare bleeding disorder due to the development of specific autoantibodies against factor VIII. The anti-CD20 monoclonal antibody Rituximab has been proven to be effective in obtaining a long-term suppression of inhibitors of AHA, besides other immunosuppressive standa...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Mediterr J Hematol Infect Dis |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Università Cattolica del Sacro Cuore
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4344169/ https://ncbi.nlm.nih.gov/pubmed/25745551 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2015.024 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|